#United States #AI Technology #HT Vista #Canine Screening #Hillside, New Jersey

HT Vista Launches New Diagnostic Feature for Dog Tumor Screening

HT Vista Ltd. has taken a significant step forward in veterinary diagnostics by unveiling a groundbreaking update to its HT Vista screening device, designed specifically for assessing lumps on dogs. This new diagnostic feature was officially launched on March 6, 2025, and is already making waves among veterinary professionals and pet owners alike.

Enhanced Cancer Screening Capability

The HT Vista device now integrates an advanced AI algorithm that facilitates the diagnosis of potential tumors with an impressive specificity rate of over 90%. This means veterinarians can quickly and effectively categorize lumps based on their likelihood of malignancy. Unlike traditional methods, which often require invasive procedures to reach a diagnosis, HT Vista's new diagnostic function empowers veterinary teams with a tool that enhances patient management without the associated risks.

Simplified Risk Assessment

The update introduces a new scoring system that replaces the previously used numerical HDI (Heat Diffusion Imaging) scores. This scoring system ranges from low, moderate, to high cancer risk, simplifying the interpretation for clinicians and making it easier to communicate findings to pet owners. For example, a low cancer risk score indicates a malignant probability of 10% or less, significantly reducing the need for invasive diagnostics in these cases.

Veterinarians can now confidently inform pet owners when a lump has a low malignant potential, allowing for a less stressful experience for both parties. Furthermore, the device also identifies benign lumps, helping to alleviate the concerns of pet owners unsure of the nature of their pet's lumps.

Supporting Veterinary Professionals

Dr. Liron Levy-Hirsch, Managing Director of HT Vista, expressed his enthusiasm about the update. He stated, "This enhancement not only strengthens our existing capabilities but also provides veterinary teams with a more comprehensive decision-support system. With the capability to identify specific tumor types, we are facilitating earlier detection, which can ultimately save lives. Reducing the time it takes from suspicion to diagnosis is a game-changer for both pets and their owners."

Bridging the Gap in Diagnosis

The new features aim to bridge the ever-present gap between screening and diagnosis, eliminating the 'wait and see' approach that can often lead to stress and delayed intervention. The device offers a quick and non-invasive screening option that is reassuring for worried pet owners.

Veterinary professionals, including Dr. Anish Patel, a veterinarian and clinic owner, have observed transformative changes in their practices since incorporating the HT Vista device. Dr. Patel mentioned, "The HT Vista has changed how we approach lumps in our canine patients. Screening every lump before taking samples greatly enhances our diagnostic approach and offers quick results that are crucial for decision-making. Pet owners appreciate this non-invasive method, which further solidifies the trust in our care."

Future Outlook

HT Vista's update is not just a technological advancement; it represents a shift towards more humane and accurate veterinary care. With ongoing algorithm improvements, the device is set to become more refined, allowing for even greater accuracy in identifying lumps and determining cancer risks in the future.

For those interested in discovering more about the HT Vista device and its innovative screening technologies, the company is set to showcase its advancements at the BSAVA Congress 2025. Attendees can visit stand C42 for more information.

Conclusion

As veterinary medicine continues to evolve, HT Vista Ltd. remains at the forefront by providing solutions that enhance the lives of pets and their owners. The new diagnostic capabilities of the HT Vista screening device underscore a commitment to advancing veterinary practices and improving patient outcomes through innovative technology and care.